LEHI, UTAH / ACCESSWIRE / November 12, 2019 / Frelii, Inc. (OTC PINK:FRLI) ("Frelii" or the "Company"), a biotechnology company working to commercialize its patent-pending DNA gene sequencing ...

Presenting Author: Sharat Singh, PhD, Head of Research, Biora Therapeutics, Inc. About the BioJet™ Systemic Oral Delivery PlatformBiora's BioJet systemic oral therapeutics platform uses an ingestible ...

Buccal drug delivery systems represent an innovative strategy for the administration of therapeutic agents via the oral mucosa. This approach bypasses the hepatic first‐pass metabolism, thereby ...

Dr. Singh will also participate in a panel discussion on June 19 at 8:45 AM titled “Uncovering Innovations in Peptide Drug Delivery & Formulation for Improved Bioavailability,” alongside ...

TMB-003 is a locally delivered formulation of sitaxsentan, a highly selective endothelin receptor antagonist. The Food and Drug Administration (FDA) has granted Orphan Drug designation to TMB-003 ...